Dr. Edward F. McClay, MD
Oncologist | Medical Oncology
161 Thunder Dr Suite 106 Vista CA, 92083About
Dr. Edward McClay is an oncologist practicing in Vista, CA. Dr. McClay specializes in the care and treatment of patients with cancer. As an oncologist, Dr. McClay manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Temple University School of Medicine 1980
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Characterization of a human melanoma cell line with non-oestrogen receptor dependent tamoxifen resistance.
- Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel.
- A phase II study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma.
- Introduction: Melanoma: American and European perspectives on diagnosis and treatment.
- Adjuvant therapy for patients with high-risk malignant melanoma.
- Systemic chemotherapy for the treatment of metastatic melanoma.
- Modulation of cisplatin resistance in human malignant melanoma cells.
- Intraperitoneal therapy in the management of patients with ovarian cancer.
- A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).
- Melanoma: new biology; new therapy.
- Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer.
- Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole.
- The role of anti-tumor necrosis factor receptor agents in cancer survivors revisited.
- Surgically unresectable regional melanoma metastases in a patient with renal failure and peripheral vascular disease: are there safe and potentially effective treatments?
- A review: intraperitoneal cisplatin in the management of patients with ovarian cancer.
Clinical Trials
- Nativis Voyager for Newly Diagnosed GBM
- A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma
- MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors
- A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
- A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Treatments
- Chronic Pain
- Melanoma
- Anemia
- Skin Cancer
- Breast Cancer
- Lung Cancer
- Chronic Kidney Disease
- Lymphoma
- Ovarian Cancer
- Extra Corporeal Shockwave Therapy
Dr. Edward F. McClay, MD's Practice location
San Marcos, CA 92069Get Direction
Dr. Edward F. McClay, MD's reviews
Write ReviewPatient Experience with Dr. McClay
Recommended Articles
- Ovarian Cancer: The Cliché About Cancer That’s True
Last June, 24-year-old Dani Strumeier, a tax accountant at PwC, began to experience pain in her lower abdomen, but she brushed off going to the hospital because she knew that there would be needles there. She could not have blood drawn from her body without throwing up or passing out. Fortunately, a...
- What is Compartment Syndrome?
Compartment syndrome refers to the excessive buildup of pressure within the muscle compartments of the body. This will affect the functioning of the nerves and lead to cell death based on the intensity and duration of the pressure built up. Bleeding and inflammation after an injury usually leads to...
- Organizations That Participate in Ovarian Cancer Research
Ovarian cancer is one of the deadliest cancers affecting women today. Out of all cancers of the reproductive system, it’s the one most likely to end in fatality. About 1 out of 75 women will be diagnosed with ovarian cancer during her lifetime, and 1 out of 100 will die from the disease. With just...
- FDA Approves Breakthrough Gene Therapy Treatment for Lymphoma
Researchers have been working around the clock to find new and improved treatments for different cancers. Drugs, experiments, natural remedies, and more treatment options have been heavily explored in the search for a cure. Recently a new form of treatment has been developed by researchers that...
- Is Ovarian Cancer Terminal?
Let’s answer the question first: It depends on the stage of the disease. There are four stages of ovarian cancer, and the third and fourth are the most dangerous. The bad thing is that most cases of ovarian cancer are diagnosed in the later stages of the disease, when little can be done to save...
Nearby Providers
- Dr. Justin Persico M.D.200 W ARBOR DR SAN DIEGO CA 92103
- Dr. Ying Maggie Zeng M.D.7088 Camino DeGrazia Unit 257 San Diego CA 92111
- Dr. Carlos Jose Carrera M.D.Ucsd Medical Center San Diego CA 92103
- Barbara A Parker M.D.200 West Arbor Dr San Diego CA 92103
- Dr. Seung-yil Song M.D.7930 Frost St San Diego CA 92123
- Dr. Manorama M Reddy M.D.4533 College Ave San Diego CA 92115